Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT05594953

Outcomes Using MARS for Patients With ALF

Conditions: Alcoholic Hepatitis, Acute Liver Failure

Sex: All

Healthy volunteers: No

Enrollment: 27

Sponsor: Methodist Health System

Location: Methodist Dallas Medical Center Dallas Texas

Summary

Retrospective chart review will be conducted on patients at Methodist Dallas Medical Center, meeting the inclusion criteria from January 1, 2019 to December 15, 2020 to determine the transplant free survival and overall survival and other secondary outcome measures.

Eligibility Criteria

Inclusion Criteria: • The patient was diagnosed with: Alcoholic hepatitis; AoCLF; OR Acute fulminant liver failure • The patient underwent at least one round of dialysis using plasma exchange or MARSTM Exclusion Criteria: * Patient not meeting the inclusion criteria will be excluded. All patients who underwent MARS at MDMC will be included in the study population.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05594953). StuddyBuddy aggregates publicly available trial information.